Integrating Causal Inference with Multi-Channel Attribution for Equitable Pharmaceutical Marketing Effectiveness Evaluation

Article Sidebar

PDF
Published: 2026-02-13
Keywords:
pharmaceutical marketing attribution, causal inference, health equity evaluation, multi-channel effectiveness

Main Article Content

Zhenghao Pan
Emerging Media Studies, Boston University, MA, USA

Abstract

The pharmaceutical industry confronts significant challenges measuring marketing effectiveness across digital and traditional channels while meeting health equity mandates. Traditional attribution approaches inadequately address confounding variables in observational data, yielding suboptimal budget allocation and inequitable demographic reach. This research proposes an integrated framework combining causal inference with multi-channel attribution modeling for pharmaceutical marketing evaluation. The framework incorporates propensity score matching, Bayesian marketing mix modeling with adstock effects, and equity-aware stratification. Empirical validation demonstrates 23.4% higher predictive accuracy versus last-touch attribution while identifying effectiveness disparities across demographic subgroups. Findings provide actionable guidance for pharmaceutical marketers optimizing resource allocation while ensuring equitable medical information access across patient populations.

Article Details

Issue

Vol. 2 No. 1 (2026)

Section

Articles

How to Cite

Integrating Causal Inference with Multi-Channel Attribution for Equitable Pharmaceutical Marketing Effectiveness Evaluation. (2026). Journal of Science, Innovation & Social Impact, 2(1), 31-45. https://sagespress.com/index.php/JSISI/article/view/80

References

1. S. Dingre, V. Girbane, S. Garudkar, P. Todakari, D. Borawake, and M. Deshmukh, "Integrating artificial intelligence in pharmaceutical marketing: Enhancing engagement and efficiency," 2025.

2. A. A. Abayomi, J. C. Ogeawuchi, A. Y. Onifade, O. A. Agboola, R. E. Dosumu, and O. O. George, "Systematic review of marketing attribution techniques for omnichannel customer acquisition models," International Journal of Advanced Multidisciplinary Research and Studies, vol. 3, no. 6, pp. 1621-1633, 2023.

3. S. A. Dada, and A. D. Adekola, "Leveraging digital marketing for health behavior change: A model for engaging patients through pharmacies," International Journal of Science and Technology Research Archive, vol. 7, no. 2, pp. 050-059, 2024.

4. G. Sabapathy, "Artificial Intelligence in Pharmaceutical Commercial Operations: Transforming Sales Performance and Patient Engagement in the Digital Era," Journal of Computer Science and Technology Studies, vol. 7, no. 8, pp. 636-651, 2025.

5. M. F. Ashouri, and M. Tarassoli, "Smart data in healthcare marketing: linking digital transformation to patient behavior and branding," Social Determinants of Health, vol. 11, pp. 1-10.

6. O. V. Unanah, and O. J. Mbanugo, "Integration of AI into CRM for effective US healthcare and pharmaceutical marketing," World Journal of Advanced Research and Reviews, vol. 25, no. 02, pp. 609-630, 2025.

7. R. Haider, and G. K. Das, "From Promotion to Personalization: The Role of Artificial Intelligence in Pharmaceutical Marketing," WebLog J Med Sci. wjms. 2025. i2905, 2025.

8. Z. Dong and F. Zhang, “Deep learning-based noise suppression and feature enhancement algorithm for LED medical imaging applications,” J. Sci., Innov. Soc. Impact, vol. 1, no. 1, pp. 9–18, 2025.

9. S. Seth, and S. Ramakrishnan, "Innovations in Multi-Touch Attribution Models: Beyond Traditional Marketing Analytics in the Pharmaceutical Sector," In 2025 International Conference on Emerging Smart Computing and Informatics (ESCI), March, 2025, pp. 1-5. doi: 10.1109/esci63694.2025.10988316

10. A. Ngamvichaikit, "Leveraging design thinking for pharmaceutical digital marketing," Asian Journal of Business Research, vol. 11, no. 1, pp. 120-140, 2021. doi: 10.14707/ajbr.210102

11. T. Anthuvan, K. Maheshwari, and R. Dantu, "Trends in pharmaceutical marketing and branding research: a bibliometric analysis (2009-2023)," IIM Ranchi Journal of Management Studies, vol. 4, no. 1, pp. 55-71, 2025. doi: 10.1108/irjms-03-2024-0030

12. J. Zhang, "Deep Learning-Based Attribution Framework for Real-Time Budget Optimization in Cross-Channel Pharmaceutical Advertising: A Comparative Study of Traditional and Digital Channels," In Proceedings of the 2025 International Conference on Software Engineering and Computer Applications, June, 2025, pp. 248-254. doi: 10.1145/3747912.3747951

13. X. Ni, Y. Zhang, Y. Pu, M. Wei, and Q. Lou, "A personalized causal inference framework for media effectiveness using hierarchical bayesian market mix models," Journal of Advanced Computing Systems, vol. 3, no. 9, pp. 9-23, 2023.

14. Z. Dong and R. Jia, “Adaptive dose optimization algorithm for LED-based photodynamic therapy based on deep reinforcement learning,” J. Sustain., Policy, Pract., vol. 1, no. 3, pp. 144–155, 2025.

15. T. J. VanderWeele, and P. Ding, "Sensitivity analysis in observational research: introducing the E-value," Annals of internal medicine, vol. 167, no. 4, pp. 268-274, 2017. doi: 10.7326/m16-2607

16. Z. Pan, "AI-Powered Real-Time Effectiveness Assessment Framework for Cross-Channel Pharmaceutical Marketing: Optimizing ROI through Predictive Analytics," In Proceedings of the 2025 International Conference on Management Science and Computer Engineering, June, 2025, pp. 220-227. doi: 10.1145/3760023.3760059

17. M. Nankya, A. Mugisa, Y. Usman, A. Upadhyay, and R. Chataut, "Security and privacy in E-health systems: a review of AI and machine learning techniques," IEEE Access, 2024. doi: 10.1109/access.2024.3469215

18. Z. Dong, “Adaptive UV-C LED dosage prediction and optimization using neural networks under variable environmental conditions in healthcare settings,” J. Adv. Comput. Syst., vol. 4, no. 3, pp. 47–56, 2024.